Growth promotion of genetically modified hematopoietic progenitors using an antibody/c-Mpl chimera

Cytokine

Volumn 55, Issue 3, 2011, Pages 402-408

  Kawahara, Masahiro ^a   Chen, Jianhong ^a   Sogo, Takahiro ^a   Teng, Jinying ^a   Otsu, Makoto ^a   Onodera, Masafumi ^b   Nakauchi, Hiromitsu ^a   Ueda, Hiroshi ^a   Nagamune, Teruyuki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Antibody; Chimeric protein; Cytokine receptor; Hematopoietic stem cell; Signal transduction

Indexed keywords

BOVINE SERUM ALBUMIN; CELL PROTEIN; ERYTHROPOIETIN RECEPTOR; FLUORESCEIN; INTERLEUKIN 3; PROTEIN C MPL; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL EXPANSION; CELL LINEAGE; CELL PROLIFERATION; CELL SELECTION; CHIMERA; CONTROLLED STUDY; DNA MODIFICATION; GENETIC MANIPULATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES; B-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; FLUORESCEIN; HEMATOPOIETIC STEM CELLS; HUMANS; INTERLEUKIN-3; MICE; MICE, INBRED C57BL; RECEPTORS, ERYTHROPOIETIN; RECEPTORS, THROMBOPOIETIN; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; SINGLE-CHAIN ANTIBODIES;

EID: 79960891716     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.05.024     Document Type: Article

References (34)

1. Livnah O., Stura E.A., Middleton S.A., Johnson D.L., Jolliffe L.K., Wilson I.A. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science 1999, 283:987-990.
2. Damjanovich S., Bene L., Matko J., Alileche A., Goldman C.K., Sharrow S., et al. Preassembly of interleukin 2 (IL-2) receptor subunits on resting Kit 225 K6 T cells and their modulation by IL-2, IL-7, and IL-15: a fluorescence resonance energy transfer study. Proc Natl Acad Sci USA 1997, 94:13134-13139.
3. Giese B., Roderburg C., Sommerauer M., Wortmann S.B., Metz S., Heinrich P.C., et al. Dimerization of the cytokine receptors gp130 and LIFR analysed in single cells. J Cell Sci 2005, 118:5129-5140.
4. Tenhumberg S., Schuster B., Zhu L., Kovaleva M., Scheller J., Kallen K.J., et al. gp130 dimerization in the absence of ligand: preformed cytokine receptor complexes. Biochem Biophys Res Commun 2006, 346:649-657.
5. Remy I., Wilson I.A., Michnick S.W. Erythropoietin receptor activation by a ligand-induced conformation change. Science 1999, 283:990-993.
6. Blakely B.T., Rossi F.M., Tillotson B., Palmer M., Estelles A., Blau H.M. Epidermal growth factor receptor dimerization monitored in live cells. Nat Biotechnol 2000, 18:218-222.
7. Kawahara M., Kimura H., Ueda H., Nagamune T. Selection of genetically modified cell population using hapten-specific antibody/receptor chimera. Biochem Biophys Res Commun 2004, 315:132-138.
8. Liu W., Kawahara M., Ueda H., Nagamune T. The influence of domain structures on the signal transduction of chimeric receptors derived from the erythropoietin receptor. J Biochem 2009, 145:575-584.
9. Liu W., Kawahara M., Ueda H., Nagamune T. Construction of a fluorescein-responsive chimeric receptor with strict ligand dependency. Biotechnol Bioeng 2008, 101:975-984.
10. Sogo T., Kawahara M., Ueda H., Otsu M., Onodera M., Nakauchi H., et al. T cell growth control using hapten-specific antibody/interleukin-2 receptor chimera. Cytokine 2009, 46:127-136.
11. Tanaka K., Kawahara M., Ueda H., Nagamune T. Selection and growth regulation of genetically modified cells with hapten-specific antibody/receptor tyrosine kinase chimera. Biotechnol Prog 2009, 25:1138-1145.
12. Pihkala P., Kawahara M., Ueda H., Nagamune T. An antigen-mediated selection system for mammalian cells that produce glycosylated single-chain Fv. Biochem Biophys Res Commun 2004, 324:1165-1172.
13. Kawahara M., Ogo Y., Ueda H., Nagamune T. Improved growth response of antibody/receptor chimera attained by the engineering of transmembrane domain. Protein Eng Des Sel 2004, 17:715-719.
14. Yagi M., Ritchie K.A., Sitnicka E., Storey C., Roth G.J., Bartelmez S. Sustained ex vivo expansion of hematopoietic stem cells mediated by thrombopoietin. Proc Natl Acad Sci USA 1999, 96:8126-8131.
15. Suzuki A., Obi K., Urabe T., Hayakawa H., Yamada M., Kaneko S., et al. Feasibility of ex vivo gene therapy for neurological disorders using the new retroviral vector GCDNsap packaged in the vesicular stomatitis virus G protein. J Neurochem 2002, 82:953-960.
16. Nabekura T., Otsu M., Nagasawa T., Nakauchi H., Onodera M. Potent vaccine therapy with dendritic cells genetically modified by the gene-silencing-resistant retroviral vector GCDNsap. Mol Ther 2006, 13:301-309.
17. Sanuki S., Hamanaka S., Kaneko S., Otsu M., Karasawa S., Miyawaki A., et al. A new red fluorescent protein that allows efficient marking of murine hematopoietic stem cells. J Gene Med 2008, 10:965-971.
18. Palacios R., Steinmetz M. IL-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo. Cell 1985, 41:727-734.
19. Kitamura T., Tange T., Terasawa T., Chiba S., Kuwaki T., Miyagawa K., et al. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J Cell Physiol 1989, 140:323-334.
20. Schneider U., Schwenk H.U., Bornkamm G. Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. Int J Cancer 1977, 19:621-626.
21. Morita S., Kojima T., Kitamura T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther 2000, 7:1063-1066.
22. Burns J.C., Friedmann T., Driever W., Burrascano M., Yee J.K. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci USA 1993, 90:8033-8037.
23. Ory D.S., Neugeboren B.A., Mulligan R.C. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc Natl Acad Sci USA 1996, 93:11400-11406.
24. Ema H., Takano H., Sudo K., Nakauchi H. In vitro self-renewal division of hematopoietic stem cells. J Exp Med 2000, 192:1281-1288.
25. Osawa M., Hanada K., Hamada H., Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 1996, 273:242-245.
26. Lok S., Kaushansky K., Holly R.D., Kuijper J.L., Lofton-Day C.E., Oort P.J., et al. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 1994, 369:565-568.
27. Park H., Hong H.J. Development of an in vitro bioassay system for human thrombopoietin by constructing a recombinant murine cell line expressing human thrombopoietin receptor. Mol Cells 1997, 7:699-704.
28. Kaushansky K. The molecular mechanisms that control thrombopoiesis. J Clin Invest 2005, 115:3339-3347.
29. Matsumura I., Nakajima K., Wakao H., Hattori S., Hashimoto K., Sugahara H., et al. Involvement of prolonged RAS activation in thrombopoietin-induced megakaryocytic differentiation of a human factor-dependent hematopoietic cell line. Mol Cell Biol 1998, 18:4282-4290.
30. Takatoku M., Kametaka M., Shimizu R., Miura Y., Komatsu N. Identification of functional domains of the human thrombopoietin receptor required for growth and differentiation of megakaryocytic cells. J Biol Chem 1997, 272:7259-7263.
31. Staerk J., Lacout C., Sato T., Smith S.O., Vainchenker W., Constantinescu S.N. An amphipathic motif at the transmembrane-cytoplasmic junction prevents autonomous activation of the thrombopoietin receptor. Blood 2006, 107:1864-1871.
32. Kume A., Ito K., Ueda Y., Hasegawa M., Urabe M., Mano H., et al. A G-CSF receptor-gyrase B fusion gene: A new type of molecular switch for expansion of genetically modified hematopoietic cells. Biochem Biophys Res Commun 1999, 260:9-12.
33. Xu R., Kume A., Matsuda K.M., Ueda Y., Kodaira H., Ogasawara Y., et al. A selective amplifier gene for tamoxifen-inducible expansion of hematopoietic cells. J Gene Med 1999, 1:236-244.
34. Jin L., Zeng H., Chien S., Otto K.G., Richard R.E., Emery D.W., et al. In vivo selection using a cell-growth switch. Nat Genet 2000, 26:64-66.